---
title: 'Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies
  and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA
  substudy'
date: '2024-07-12'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38993854/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240712181613&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The studied combinations of immunosuppressants were safe
  with no influence on clinical outcomes and suggested minimal exposure of calcineurin
  inhibitors for better patient ...'
disable_comments: true
---
CONCLUSIONS: The studied combinations of immunosuppressants were safe with no influence on clinical outcomes and suggested minimal exposure of calcineurin inhibitors for better patient ...